Jun 14, 2019 / 02:30PM GMT
Pindaros Roy Vagelos - Regeneron Pharmaceuticals, Inc. - Chairman of the Board
Okay. Good morning, ladies and gentlemen, and welcome. Welcome also to those attending the meeting via our webcast. It's 10:30 and time to call the Annual Meeting of Shareholders of Regeneron Pharmaceuticals to order. I am Roy Vagelos, Chairman of the Board.
On my left is Len Schleifer, President and Chief Executive Officer and a member of the Board of Directors of Regenferon. On Dr. Schleifer's left is Joe LaRosa, Executive Vice President, General Counsel and Corporate Secretary and secretary of this meeting.
Also present this morning are other senior officers of Regeneron. I'll ask them to stand when I introduce them. George Yancopoulos, Founding Scientist, President and Chief Scientific Officer. George is also a member of the company's Board of Directors.
Bob Landry, Executive Vice President, Finance and Financial -- Chief Financial Officer; Drew Murphy, Executive Vice President of Research; Hanne Bak, Senior Vice President, Preclinical Manufacturing and Process Development; Aris Baras, Senior
Regeneron Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Jun 14, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers